Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's Macroglobulinemia.
N Engl J Med
; 378(25): 2399-2410, 2018 Jun 21.
Article
in En
| MEDLINE
| ID: mdl-29856685
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyrimidines
/
Antineoplastic Combined Chemotherapy Protocols
/
Waldenstrom Macroglobulinemia
/
Rituximab
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2018
Type:
Article